Clinical Trial

A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
The researchers are doing this study to see how well multiparametric ultrasound (mpUS) imaging can evaluate vaginal tissue before and after IVRT. IVRT is routinely used to treat endometrial cancer but can cause damage to the vaginal tissue (vaginal toxicity). Side effects of vaginal toxicity can include vaginal dryness, itching, soreness, discharge, narrowing or shortening of the vagina (stenosis), and vaginal fibrosis (hardening), which can affect sexual function. The researchers will also look at whether participants are able to complete (tolerate) all mpUS imaging for this study.
Trial Details
NCT Number NCT07318415
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions Endometrial Cancer
Enrollment 10 participants
Start Date 2025-12-11
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-06